Clinical Trial

The Coronary Sinus Balloon Pump in STEMI

Study acronym: REVIVE-RCT
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 21, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a prospective, multicenter, randomized controlled clinical trial designed to evaluate the safety and efficacy of the coronary sinus balloon pump (manufactured by Shanghai MicroPort Rotapace Medical Technology Co., Ltd.) as an adjunctive therapy during percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI). As a pivotal study, it aims to support the product registration application to the National Medical Products Administration (NMPA).
Trial Details
NCT Number NCT07354035
Lead Sponsor Shanghai MicroPort Rhythm MedTech Co., Ltd.
Conditions STEMI
Enrollment 177 participants
Start Date 2026-02-12
Primary Completion 2026-05 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-01-21